| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |